logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Chimicles Biotech-B (02509.HK) spent 99.82 million Hong Kong dollars on November 21 to repurchase 49,200 shares.

date
21/11/2025
Wisdom Financial APP News, Quantum Corporation-B (02509.HK) has announced that it will spend 998,200 Hong Kong dollars to repurchase 49,200 shares on November 21, 2025.
Latest
1 m ago
In the third quarter, Peru's GDP grew by 3.4% year-on-year, in line with the estimated growth of 3.4%.
2 m ago
Beijing Automotive Group (01958.HK) plans to sell a 51% stake in Beiqi International for approximately 1.608 billion yuan.
3 m ago
Stone Medicine Group (01093): Selective 5-HT2A receptor agonist (SYH2056 tablet) approved for clinical trials in China.
4 m ago
Thunder God Technology Company has won a $1.25 billion contract to produce Tamir missiles and will set up a factory in Camden, Arkansas.
4 m ago
Botech Carlink (02889.HK): Huzhou Chuangchengming Equity Investment intends to sell 0.24% equity of Aweita Technology (Chongqing) for 62.44 million yuan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.